After three tries BYDUREON, the once-a-week version of Byetta received FDA approval last Friday, Jan. 27. The approval follows two earlier rejections by the FDA, which each time asked for more data. BYETTA® (exenatide) ...

Byetta (Exenatide) is an injectable drug that is prescribed for people with type 2 diabetes. Exenatide is an incretin mimetic since it mimics incretins, a natural hormone in the body. Exenatide helps the pancreas produce insulin ...

The first GLP-1 drug to receive FDA approval was Byetta®, which is injected twice daily into the abdomen, thigh or shoulder an hour before breakfast and dinner. Victoza® is a long-acting GLP-1 agonist injected once daily.

It may be necessary for them to take a number of different oral medications to control their diabetes but their doctor may also feel that they should purchase Byetta (Exenatide) online as well. When you control your blood sugar ...

According to the FDA, the diabetes injection Byetta has been associated with serious and potentially fatal side effects for some users. There have been reports of acute pancreatitis associated with the injection. Pancreatitis is a ...

“At this year's EASD, we are pleased to share data that deepen our understanding of the safety and efficacy of BYETTA, together with the possible benefits of BYDUREON,” stated Orville G. Kolterman, M.D., senior vice ...

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company announced Oct. 19, that the FDA has approved a new use for BYETTA® (exenatide) injection for those using the insulin glargine (Lantus®) with or without metformin ...

The European Association for the Study of Diabetes will meet in Lisbon to debate the connection between diabetes medications like Byetta and cancer. The manufacturers of the drugs claim both category GLP-1 diabetes drugs are safe and ...

Medical billing firm providing medical billing services and medical billing consulting throughout the state of Michigan.